Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



These Companies Are Small and Growing

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some small-cap growth stocks to your portfolio but don't have the time or expertise to hand-pick a few, the iShares S&P Small Cap 600 Growth ETF (NYSEMKT: IJT  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.

The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The iShares ETF's expense ratio -- its annual fee -- is a low 0.26 %.

This ETF has performed well, topping the large-cap S&P 500 index over the past three, five, and 10 years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

Why small-cap growth stocks?
It's smart to include smaller companies in your portfolio, as the best of them can grow rapidly and eventually become large caps. It's smart to seek undervalued stocks, as value investors do. But it can also be appealing to add some "growth" stocks to your portfolio, in the hope of juicing its overall performance. Such stocks offer significant growth potential, and some of them are undervalued, too.

More than a handful of small-cap growth companies had strong performances over the past year. Questcor Pharmaceuticals (UNKNOWN: QCOR.DL  ) tripled, gaining more than 30% on July 31 alone, after the company posted very solid second-quarter earnings. Earnings were up 72% over year-ago levels, with revenue up 64%. Questcor is largely known for its multiple-sclerosis (MS) drug, Acthar, that has sold well  in the past, and is being evaluated for many more indications, such as in pulmonology. Questcor's management is extremely well regarded and its dividend was hiked by 25% earlier this year. Even with its stock-price rise, it looks attractive. The stock took a bit of a hit recently on news of some insider selling. But insider selling isn't necessarily ominous. Some criticize Questcor for being too centered on Acthar, but it's doing a lot with the drug and has been performing quite well.

Portfolio Recovery Associates (NASDAQ: PRAA  ) surged 73%, and is near a 52-week high. Portfolio Recovery is a debt collector, buying defaulted debt from lenders and then collecting pennies on the dollar -- which still results in healthy profits. Indeed, the company's net margin was recently above 20%. Free cash flow has roughly doubled from $81 million in 2009 to $164 million in 2013. Analysts at Zacks recently upgraded the stock to a strong buy on its improved performance and growth.

ViroPharma (UNKNOWN: VPHM.DL  ) jumped 28%, in large part on speculation that the maker of drugs for rare diseases will be bought out at a premium. Think twice before making investment decisions based on speculation, though. Analysts at Merrill Lynch have downgraded the stock based on risks tied to its key product, Cinryze, which treats the rare condition of hereditary angioedema.

Darling International (NYSE: DAR  ) , a food-waste recycler and the nation's biggest publicly traded renderer, gained 18% -- in part for its promising acquisition of a rendering and biodiesel business and its international expansion. Bulls are excited that its biodiesel joint venture with Valero Energy is now up and running, and some see it as a good time to buy into the company. Analysts at Cannacord Genuity recently upgraded the stock from hold to buy, but Zacks downgraded it to strong sell. Darling's net income and free cash flow have fallen in recent years, but they're solidly in the black.

A well-chosen ETF can grant you instant diversification across any industry or group of companies -- and make investing in and profiting from it that much easier.


So many to choose from
This isn't the only interesting ETF out there. You can learn more about a few ETFs that have great promise for delivering profits to shareholders by checking out The Motley Fool's special free report "3 ETFs Set to Soar." Just click here to access it now.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On September 24, 2013, at 6:21 PM, OneOtherFool wrote:

    "The stock took a bit of a hit recently on news of some insider selling."

    I'm not sure if that's true. That was not the reason for the sell off....

    Similar insider selling has happened in the upper $40s(on 7/15 and 6/15), before the gap up. There were even much more shares sold back then. Similarly, there was insider selling in the 30s, before the run to the $40s. He/she who pulled out when those sell orders occurred, would have missed out on >100% gains. and I have a feeling the same will happen again, soon.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2652596, ~/Articles/ArticleHandler.aspx, 10/27/2016 5:20:57 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 4:02 PM
DAR $13.44 Down -0.15 -1.10%
Darling Ingredient… CAPS Rating: ****
IJT $129.39 Down -1.54 -1.18%
iShares S and P Sm… CAPS Rating: **
PRAA $31.50 Down +0.00 +0.00%
PRA Group CAPS Rating: *****
QCOR.DL $0.00 Down +0.00 +0.00%
Questcor Pharmaceu… CAPS Rating: **
VPHM.DL $0.00 Down +0.00 +0.00%
ViroPharma CAPS Rating: ***